177 related articles for article (PubMed ID: 36261421)
21. ING5 activity in self-renewal of glioblastoma stem cells via calcium and follicle stimulating hormone pathways.
Wang F; Wang AY; Chesnelong C; Yang Y; Nabbi A; Thalappilly S; Alekseev V; Riabowol K
Oncogene; 2018 Jan; 37(3):286-301. PubMed ID: 28925404
[TBL] [Abstract][Full Text] [Related]
22. ARPC1B promotes mesenchymal phenotype maintenance and radiotherapy resistance by blocking TRIM21-mediated degradation of IFI16 and HuR in glioma stem cells.
Gao Z; Xu J; Fan Y; Zhang Z; Wang H; Qian M; Zhang P; Deng L; Shen J; Xue H; Zhao R; Zhou T; Guo X; Li G
J Exp Clin Cancer Res; 2022 Nov; 41(1):323. PubMed ID: 36380368
[TBL] [Abstract][Full Text] [Related]
23. Increased Notch Signaling Enhances Radioresistance of Malignant Stromal Cells Induced by Glioma Stem/ Progenitor Cells.
Shen Y; Chen H; Zhang J; Chen Y; Wang M; Ma J; Hong L; Liu N; Fan Q; Lu X; Tian Y; Wang A; Dong J; Lan Q; Huang Q
PLoS One; 2015; 10(11):e0142594. PubMed ID: 26599017
[TBL] [Abstract][Full Text] [Related]
24. Histone deacetylase inhibitors exert anti-tumor effects on human adherent and stem-like glioma cells.
Was H; Krol SK; Rotili D; Mai A; Wojtas B; Kaminska B; Maleszewska M
Clin Epigenetics; 2019 Jan; 11(1):11. PubMed ID: 30654849
[TBL] [Abstract][Full Text] [Related]
25. Integrin α6 signaling induces STAT3-TET3-mediated hydroxymethylation of genes critical for maintenance of glioma stem cells.
Herrmann A; Lahtz C; Song J; Aftabizadeh M; Cherryholmes GA; Xin H; Adamus T; Lee H; Grunert D; Armstrong B; Chu P; Brown C; Lim M; Forman S; Yu H
Oncogene; 2020 Mar; 39(10):2156-2169. PubMed ID: 31819166
[TBL] [Abstract][Full Text] [Related]
26. Acidic stress promotes a glioma stem cell phenotype.
Hjelmeland AB; Wu Q; Heddleston JM; Choudhary GS; MacSwords J; Lathia JD; McLendon R; Lindner D; Sloan A; Rich JN
Cell Death Differ; 2011 May; 18(5):829-40. PubMed ID: 21127501
[TBL] [Abstract][Full Text] [Related]
27. The opposing effect of hypoxia-inducible factor-2alpha on expression of telomerase reverse transcriptase.
Lou F; Chen X; Jalink M; Zhu Q; Ge N; Zhao S; Fang X; Fan Y; Björkholm M; Liu Z; Xu D
Mol Cancer Res; 2007 Aug; 5(8):793-800. PubMed ID: 17699105
[TBL] [Abstract][Full Text] [Related]
28. Targeting of glioma stem-like cells with a parthenolide derivative ACT001 through inhibition of AEBP1/PI3K/AKT signaling.
Hou Y; Sun B; Liu W; Yu B; Shi Q; Luo F; Bai Y; Feng H
Theranostics; 2021; 11(2):555-566. PubMed ID: 33391492
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic regulation of CD133/PROM1 expression in glioma stem cells by Sp1/myc and promoter methylation.
Gopisetty G; Xu J; Sampath D; Colman H; Puduvalli VK
Oncogene; 2013 Jun; 32(26):3119-29. PubMed ID: 22945648
[TBL] [Abstract][Full Text] [Related]
30. Tumor vasculature and glioma stem cells: Contributions to glioma progression.
Jhaveri N; Chen TC; Hofman FM
Cancer Lett; 2016 Oct; 380(2):545-551. PubMed ID: 25527451
[TBL] [Abstract][Full Text] [Related]
31. CRNDE acts as an epigenetic modulator of the p300/YY1 complex to promote HCC progression and therapeutic resistance.
Liu YC; Lin YH; Chi HC; Huang PS; Liao CJ; Liou YS; Lin CC; Yu CJ; Yeh CT; Huang YH; Lin KH
Clin Epigenetics; 2022 Aug; 14(1):106. PubMed ID: 35999564
[TBL] [Abstract][Full Text] [Related]
32. Glioma stem cells-derived exosomes promote the angiogenic ability of endothelial cells through miR-21/VEGF signal.
Sun X; Ma X; Wang J; Zhao Y; Wang Y; Bihl JC; Chen Y; Jiang C
Oncotarget; 2017 May; 8(22):36137-36148. PubMed ID: 28410224
[TBL] [Abstract][Full Text] [Related]
33. Glioma stem-like cells evade interferon suppression through MBD3/NuRD complex-mediated STAT1 downregulation.
Zhan X; Guo S; Li Y; Ran H; Huang H; Mi L; Wu J; Wang X; Xiao D; Chen L; Li D; Zhang S; Yan X; Yu Y; Li T; Han Q; He K; Cui J; Li T; Zhou T; Rich JN; Bao S; Zhang X; Li A; Man J
J Exp Med; 2020 May; 217(5):. PubMed ID: 32181805
[TBL] [Abstract][Full Text] [Related]
34. Fractionated radiation-induced nitric oxide promotes expansion of glioma stem-like cells.
Kim RK; Suh Y; Cui YH; Hwang E; Lim EJ; Yoo KC; Lee GH; Yi JM; Kang SG; Lee SJ
Cancer Sci; 2013 Sep; 104(9):1172-7. PubMed ID: 23714583
[TBL] [Abstract][Full Text] [Related]
35. E2F and STAT3 provide transcriptional synergy for histone variant H2AZ activation to sustain glioblastoma chromatin accessibility and tumorigenicity.
Yoon J; Grinchuk OV; Tirado-Magallanes R; Ngian ZK; Tay EXY; Chuah YH; Lee BWL; Feng J; Crasta KC; Ong CT; Benoukraf T; Ong DST
Cell Death Differ; 2022 Jul; 29(7):1379-1394. PubMed ID: 35058574
[TBL] [Abstract][Full Text] [Related]
36. IGF1 receptor signaling regulates adaptive radioprotection in glioma stem cells.
Osuka S; Sampetrean O; Shimizu T; Saga I; Onishi N; Sugihara E; Okubo J; Fujita S; Takano S; Matsumura A; Saya H
Stem Cells; 2013 Apr; 31(4):627-40. PubMed ID: 23335250
[TBL] [Abstract][Full Text] [Related]
37. RGFP966, a histone deacetylase 3 inhibitor, promotes glioma stem cell differentiation by blocking TGF-β signaling via SMAD7.
Liang H; Wang Q; Wang D; Zheng H; Kalvakolanu DV; Lu H; Wen N; Chen X; Xu L; Ren J; Guo B; Zhang L
Biochem Pharmacol; 2020 Oct; 180():114118. PubMed ID: 32585142
[TBL] [Abstract][Full Text] [Related]
38. Down-modulation of SEL1L, an unfolded protein response and endoplasmic reticulum-associated degradation protein, sensitizes glioma stem cells to the cytotoxic effect of valproic acid.
Cattaneo M; Baronchelli S; Schiffer D; Mellai M; Caldera V; Saccani GJ; Dalpra L; Daga A; Orlandi R; DeBlasio P; Biunno I
J Biol Chem; 2014 Jan; 289(5):2826-38. PubMed ID: 24311781
[TBL] [Abstract][Full Text] [Related]
39. Histone Acetyltransferases p300 and CBP Coordinate Distinct Chromatin Remodeling Programs in Vascular Smooth Muscle Plasticity.
Chakraborty R; Ostriker AC; Xie Y; Dave JM; Gamez-Mendez A; Chatterjee P; Abu Y; Valentine J; Lezon-Geyda K; Greif DM; Schulz VP; Gallagher PG; Sessa WC; Hwa J; Martin KA
Circulation; 2022 Jun; 145(23):1720-1737. PubMed ID: 35502657
[TBL] [Abstract][Full Text] [Related]
40. Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells.
Orzan F; Pellegatta S; Poliani PL; Pisati F; Caldera V; Menghi F; Kapetis D; Marras C; Schiffer D; Finocchiaro G
Neuropathol Appl Neurobiol; 2011 Jun; 37(4):381-94. PubMed ID: 20946108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]